Pharmacoeconomic analysis of HBV liver transplant therapies

Clinical Transplantation

Volumn 14, Issue SUPPL. 2, 2000, Pages 29-38

  McGory, R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

HBlg; Hepatitis B; Insurance; Liver; Pharmacoeconomics; Transplantation

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; NUCLEOSIDE ANALOG; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG COST; DRUG HALF LIFE; DRUG MEGADOSE; ECONOMIC ASPECT; GRAFT INFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION CONTROL; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; COST CONTROL; COST-BENEFIT ANALYSIS; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL CHARGES; HOSPITAL COSTS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LIVER TRANSPLANTATION; PURCHASING, HOSPITAL; SAFETY; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0033852099     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hepatitis viruses and liver transplantation
2. Liver transplantation in European patients with the hepatitis B surface antigen
3. Long-term follow-up of hepatitis B-virus infected recipients after orthotopic liver transplantation
4. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization
5. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin
6. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive
7. Rapid conversion of serum HBsAg status following liver transplant for chronic HBV affects the rate of early allograft infection
8. Prediction of anti-HBs elimination following OLTX for HBV cirrhosis by quantification of pre-transplant serum hepatitis B surface antigen, e antigen and DNA
9. Is hepatitis B infection an indication for orthotopic liver transplantation? The answer, my friend, is blowin' in the wind
10. Hepatitis B infection and liver transplantation: The art of the possible
11. Liver transplantation for hepatitis B: The con aspect
12. Mercury poisoning associated with hepatitis B immunoglobulin
13. Liver transplantation for hepatitis B cirrhosis: Clinical sequela of passive immunization
14. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
15. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
16. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin
17. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation/
18. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
19. Overcoming HBV post-liver transplant recurrence: An almost 5-year experience
20. A long-term follow-up of combination HBIg and lamivudine in preventing recurrent hepatitis B in 61 orthotopic liver transplant (OLT) recipients
21. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIg) prophylaxis after liver transplantation
22. Comparison of immune reactivity and pharmacokinetic of two hepatitis B immune globulins in patients after liver transplantation
23. Immunoprophylaxis with hepatitis B immunoglobulin after transplantation: An economical approach
24. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation
25. Intramuscular hepatitis B immune globulin prophylaxis for recurrent hepatitis B